PU23.03 Being a part of the conversation: capacitating youth to participate in HIV prevention conversations using a digital citizen engagement platform in South AfricaPublication OnlyPolicy and advocacy
PU21.08 Distinct classes of HIV-1 cross-clade neutralizing antibodies targeting fusion peptide elicited in mice by diverse immunization regimensPublication OnlyNovel vaccine and other prevention approaches
PU21.06 DNA vs ChAd-vectored vaccines as priming vaccines in heterologous prime-boost regimens to increase HTI immunogenicity in micePublication OnlyNovel vaccine and other prevention approaches
PU21.03 Co-display of hyperstabilized HIV-1 envelope glycoprotein trimers on two-component protein nanoparticlesPublication OnlyNovel vaccine and other prevention approaches
PU21.03 Assessment of crosslinker suitability for fusion peptide conjugates as priming immunogens for an HIV-1 vaccinePublication OnlyNovel vaccine and other prevention approaches
PU21.02 Comparison of HIV incidence in simulated vaccine efficacy trials and observational cohorts using propensity scores in key populations in UgandaPublication OnlyNovel vaccine and other prevention approaches
PU21.01 Willingness of adolescent girls and young women in Kampala, Uganda to participate in future efficacyttrials of novel biomedical HIV prevention interventions: the anti-retroviral implantPublication OnlyNovel vaccine and other prevention approaches
PU20.02 Asymptomatic bacterial STI in young men who have sex with men minimally alters rectal mucosal immune cell ecosystemPublication OnlyMucosal immunity
PU20.01 Vaccination with Ad26.ZEBOV, MVA-BN-Filo or MVA-BN-Filo, Ad26.ZEBOV induced predominantly IgG binding to Ebola glycoprotein in cervico-vaginal mucus in HIV-infected and uninfected participantsPublication OnlyMucosal immunity
PU19.01 The impact of vaginal Lactobacillus isolates on host gene expression involved in inflammation in the female genital tractPublication OnlyMicrobiome & STI: impact on prevention
seek-warrow-warrow-eseek-e11 - 20 of 444 items